COM-IT-2 Immunotherapy combined with extensive radiotherapy for the treatment of stage IV non-small cell lung cancer
![](https://www.ous-research.no/helland/images/COM-IT-logo.jpeg)
– a phase II randomised clinical and translational trial
- EudraCT number: 2021-003266
Background/study objectives |
Study design |
Collaborative partners |
Update/publications |